$3.890
-0.226 (-5.81%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
ORMP-Prognose durch Analyse ähnlicher Charts
Alphio's ORMP stock price prediction model matches the current Oramed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.90 (+0.38%). The 1-week path is $3.90 (+0.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Oramed Pharmaceuticals Inc-Aktien kaufen?
Oramed Pharmaceuticals Inc is currently trading at $4, which is 56.5% of its 52-week range, indicating it is closer to its 52-week high of $5.47. However, the RSI is at a low 29.89, suggesting the stock is oversold. The company reported a profit of $10 million in Q4, translating to an EPS of $0.24, which reflects strong profitability despite low revenue. The main risk is the significant drop in revenue with total revenue reported as $2 million in Q1 2025 and a projected earnings surprise of -120.93% in the last earnings report, indicating potential volatility ahead.
ORMP schloss am Thursday bei $3.89, nachdem der Kurs -5.81% fallen
Oramed Pharmaceuticals Inc (ORMP) last closed at $3.8900001, losing -5.81%. These facts feed the 1-day and 1-week ORMP price prediction above.
Analystenkonsens
Oramed Pharmaceuticals Inc (ORMP): 2 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von Oramed Pharmaceuticals Inc (ORMP) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf ORMP am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für ORMP
Historically the probability of a positive November return for ORMP is 32.56%. December offers the highest probability of a positive month at 74.42%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für ORMP
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $1.92 | $2.16 | $2.28 | -44.39% |
| Dec 2026 | $2.47 | $2.51 | $2.54 | -35.53% |
Für 2026 wird für Oramed Pharmaceuticals Inc (ORMP) eine Spanne von $1.92 bis $2.54 projiziert.
Monatsprognose 2026 für Oramed Pharmaceuticals Inc
Im Nov 2026 wird für Oramed Pharmaceuticals Inc ein Durchschnitt von $2.16 erwartet, mit einem Tief von $1.92 und einem Hoch von $2.28.
Im Dec 2026 wird für Oramed Pharmaceuticals Inc ein Durchschnitt von $2.51 erwartet, mit einem Tief von $2.47 und einem Hoch von $2.54.
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.